• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

缺氧调节蛋白:在子宫内膜癌中的表达及其与临床病理特征的关联

Hypoxia-Regulated Proteins: Expression in Endometrial Cancer and Their Association with Clinicopathologic Features.

作者信息

Song Dae Hyun, Jo Jae Yoon, Kim Cho Hee, Kim Min Hye, Cho In Ae, Shin Jeong Kyu, Choi Won Jun, Baek Jong Chul

机构信息

Department of Pathology, Gyeongsang National University School of Medicine, Gyeongsang National University Changwon Hospital, 11, Changwon-si 51472, Republic of Korea.

Institute of Medical Science, Gyeongsang National University, Jinju 52727, Republic of Korea.

出版信息

Diagnostics (Basel). 2024 Aug 9;14(16):1735. doi: 10.3390/diagnostics14161735.

DOI:10.3390/diagnostics14161735
PMID:39202223
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11353210/
Abstract

BACKGROUND

Hypoxia-regulated proteins (HIF-1α and GLUT-1) have been identified as prognostic markers in various cancers; however, their role in endometrial cancer remains unclear. This study aimed to evaluate HIF-1α and GLUT-1 expression in endometrial cancer and correlate their expression with clinicopathological features.

MATERIALS AND METHODS

A tissue microarray (TMA) was constructed using specimens from a retrospective cohort of 51 endometrial cancer patients who underwent hysterectomy at the Gyeongsang National University Hospital between 2002 and 2009. Clinicopathologic data were collected from electronic medical records, and HIF-1α and GLUT-1 expressions were assessed in the tumor tissue.

RESULTS

GLUT-1 expression in endometrial cancer was categorized as mosaic, central, or diffuse. Most patients (56.0%) exhibited a central pattern, followed by diffuse (32.0%) and mosaic (12.0%) patterns. GLUT-1 expression was not significantly associated with histologic grade ( = 0.365). HIF-1α expression in immune cells, but not tumor cells, was significantly associated with a higher histologic grade. A higher proportion of HIF-1α-positive immune cells, using both thresholds (≤1% vs. >1% and ≤5% vs. >5%), was significantly associated with higher histologic grade ( = 0.032 and = 0.048, respectively). In addition, a higher proportion of HIF-1α-positive immune cells was significantly associated with a diffuse GLUT-1 expression pattern using >5% as a threshold. There were no significant differences in the proportion of HIF-1α-positive immune cells between groups stratified by age, tumor size, or invasion depth, regardless of whether the 1% or 5% threshold for HIF-1α positivity was used.

CONCLUSIONS

A higher proportion of HIF-1α-positive immune cells is associated with endometrial cancers with higher histologic grade and diffuse GLUT1 expression patterns. These findings suggest a potential role for HIF-1α as a prognostic marker and highlight the need for further studies into the role of HIF-1α in the tumor microenvironment.

摘要

背景

缺氧调节蛋白(HIF-1α和GLUT-1)已被确定为多种癌症的预后标志物;然而,它们在子宫内膜癌中的作用仍不清楚。本研究旨在评估HIF-1α和GLUT-1在子宫内膜癌中的表达,并将其表达与临床病理特征相关联。

材料与方法

使用2002年至2009年间在庆尚国立大学医院接受子宫切除术的51例子宫内膜癌患者的回顾性队列标本构建组织微阵列(TMA)。从电子病历中收集临床病理数据,并在肿瘤组织中评估HIF-1α和GLUT-1的表达。

结果

子宫内膜癌中GLUT-1的表达分为镶嵌型、中央型或弥漫型。大多数患者(56.0%)表现为中央型,其次是弥漫型(32.0%)和镶嵌型(12.0%)。GLUT-1表达与组织学分级无显著相关性(=0.365)。免疫细胞而非肿瘤细胞中的HIF-1α表达与较高的组织学分级显著相关。使用两个阈值(≤1%与>1%以及≤5%与>5%)时,较高比例的HIF-1α阳性免疫细胞与较高的组织学分级显著相关(分别为=0.032和=0.048)。此外,以>5%为阈值时,较高比例的HIF-1α阳性免疫细胞与弥漫性GLUT-1表达模式显著相关。无论使用1%还是5%的HIF-1α阳性阈值,按年龄、肿瘤大小或浸润深度分层的组间HIF-1α阳性免疫细胞比例均无显著差异。

结论

较高比例的HIF-1α阳性免疫细胞与组织学分级较高和弥漫性GLUT1表达模式的子宫内膜癌相关。这些发现提示HIF-1α作为预后标志物的潜在作用,并强调需要进一步研究HIF-1α在肿瘤微环境中的作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16e7/11353210/78e4c25d0003/diagnostics-14-01735-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16e7/11353210/15143cfa2cef/diagnostics-14-01735-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16e7/11353210/78e4c25d0003/diagnostics-14-01735-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16e7/11353210/15143cfa2cef/diagnostics-14-01735-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16e7/11353210/78e4c25d0003/diagnostics-14-01735-g002.jpg

相似文献

1
Hypoxia-Regulated Proteins: Expression in Endometrial Cancer and Their Association with Clinicopathologic Features.缺氧调节蛋白:在子宫内膜癌中的表达及其与临床病理特征的关联
Diagnostics (Basel). 2024 Aug 9;14(16):1735. doi: 10.3390/diagnostics14161735.
2
HIF-1α and GLUT-1 Expression in Atypical Endometrial Hyperplasia, Type I and II Endometrial Carcinoma: A Potential Role in Pathogenesis.缺氧诱导因子-1α(HIF-1α)和葡萄糖转运蛋白-1(GLUT-1)在非典型子宫内膜增生、Ⅰ型和Ⅱ型子宫内膜癌中的表达:在发病机制中的潜在作用
J Clin Diagn Res. 2016 May;10(5):EC20-7. doi: 10.7860/JCDR/2016/19576.7805. Epub 2016 May 1.
3
The role of Hypoxia-inducible factor-1 α , glucose transporter-1, (GLUT-1) and carbon anhydrase IX in endometrial cancer patients.缺氧诱导因子-1α、葡萄糖转运蛋白-1(GLUT-1)和碳酸酐酶IX在子宫内膜癌患者中的作用。
Biomed Res Int. 2014;2014:616850. doi: 10.1155/2014/616850. Epub 2014 Mar 12.
4
Expression of programmed death-ligand 1 and hypoxia-inducible factor-1α proteins in endometrial carcinoma.程序性死亡配体1和缺氧诱导因子-1α蛋白在子宫内膜癌中的表达
J Cancer Res Ther. 2018 Dec;14(Supplement):S1063-S1069. doi: 10.4103/0973-1482.202891.
5
Differential prognostic impact of hypoxia induced and diffuse HIF-1alpha expression in invasive breast cancer.缺氧诱导和弥漫性HIF-1α表达在浸润性乳腺癌中的差异预后影响
J Clin Pathol. 2005 Feb;58(2):172-7. doi: 10.1136/jcp.2004.019885.
6
Clinicopathological implications of the expression of hypoxia-related proteins in gastric cancer.胃癌中缺氧相关蛋白表达的临床病理意义。
Int J Med Sci. 2013 Jul 31;10(9):1217-23. doi: 10.7150/ijms.6054. Print 2013.
7
Necrosis related HIF-1alpha expression predicts prognosis in patients with endometrioid endometrial carcinoma.缺氧诱导因子-1α的表达与子宫内膜样腺癌患者的预后相关。
BMC Cancer. 2010 Jun 19;10:307. doi: 10.1186/1471-2407-10-307.
8
Distribution of Hypoxia-Inducible Factor-1α and Glucose Transporter-1 in Human Tongue Cancers.缺氧诱导因子-1α和葡萄糖转运蛋白-1在人舌癌中的分布
J Oral Maxillofac Surg. 2015 Sep;73(9):1753-60. doi: 10.1016/j.joms.2015.03.013. Epub 2015 Mar 18.
9
Clinicopathological significance and linkage of the distribution of HIF-1alpha and GLUT-1 in human primary colorectal cancer.缺氧诱导因子-1α(HIF-1α)和葡萄糖转运蛋白-1(GLUT-1)在人原发性结直肠癌中的分布及其临床病理意义与相关性
Pathol Oncol Res. 2007;13(1):15-20. doi: 10.1007/BF02893436. Epub 2007 Mar 27.
10
Prognostic and Clinicopathological Significance of Hypoxia-Inducible Factor-1α in Endometrial Cancer: A Meta-Analysis.缺氧诱导因子-1α在子宫内膜癌中的预后及临床病理意义:一项荟萃分析
Front Oncol. 2020 Nov 11;10:587420. doi: 10.3389/fonc.2020.587420. eCollection 2020.

引用本文的文献

1
YAP/TAZ Promote GLUT1 Expression and Are Associated with Prognosis in Endometrial Cancer.YAP/TAZ促进葡萄糖转运蛋白1(GLUT1)表达并与子宫内膜癌的预后相关。
Cancers (Basel). 2025 Aug 1;17(15):2554. doi: 10.3390/cancers17152554.
2
Editorial on the Special Issue Titled "Pathology and Diagnosis of Gynecologic Diseases-2nd Edition".关于《妇科疾病的病理学与诊断(第二版)》特刊的社论
Diagnostics (Basel). 2025 Feb 4;15(3):356. doi: 10.3390/diagnostics15030356.

本文引用的文献

1
Comparison of SP142 and 22C3 PD-L1 assays in a population-based cohort of triple-negative breast cancer patients in the context of their clinically established scoring algorithms.在基于人群的三阴性乳腺癌患者队列中,比较 SP142 和 22C3 PD-L1 检测试剂盒在其临床建立的评分算法中的应用。
Breast Cancer Res. 2023 Oct 10;25(1):123. doi: 10.1186/s13058-023-01724-2.
2
Intrauterine manipulator during hysterectomy for endometrial cancer: a systematic review and meta-analysis of oncologic outcomes.子宫内膜癌子宫切除术中的宫腔操作器:肿瘤学结局的系统评价和荟萃分析
Am J Obstet Gynecol. 2024 Feb;230(2):185-198.e4. doi: 10.1016/j.ajog.2023.09.004. Epub 2023 Sep 12.
3
Prognostic impact of the combination of HIF‑1α and GLUT1 in patients with oesophageal squamous cell carcinoma.
缺氧诱导因子-1α(HIF-1α)与葡萄糖转运蛋白1(GLUT1)联合检测对食管鳞状细胞癌患者的预后影响
Oncol Lett. 2023 Jul 31;26(3):404. doi: 10.3892/ol.2023.13990. eCollection 2023 Sep.
4
FIGO staging of endometrial cancer: 2023.国际妇产科联盟(FIGO)子宫内膜癌分期:2023 年。
J Gynecol Oncol. 2023 Sep;34(5):e85. doi: 10.3802/jgo.2023.34.e85. Epub 2023 Aug 8.
5
Targeting the tumor microenvironment: Potential strategy for cancer therapeutics.靶向肿瘤微环境:癌症治疗的潜在策略。
Biochim Biophys Acta Mol Basis Dis. 2023 Aug;1869(6):166746. doi: 10.1016/j.bbadis.2023.166746. Epub 2023 May 7.
6
Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer.度伐利尤单抗治疗原发性晚期或复发性子宫内膜癌。
N Engl J Med. 2023 Jun 8;388(23):2145-2158. doi: 10.1056/NEJMoa2216334. Epub 2023 Mar 27.
7
Biomarker-driven therapy in endometrial cancer.子宫内膜癌的生物标志物驱动治疗。
Int J Gynecol Cancer. 2023 Mar 6;33(3):343-350. doi: 10.1136/ijgc-2022-003676.
8
Potential biomarkers in endometrial cancer: a narrative review.子宫内膜癌的潜在生物标志物:叙述性综述。
Biomarkers. 2023 Jun;28(4):358-371. doi: 10.1080/1354750X.2023.2179114. Epub 2023 Feb 26.
9
SP142 evaluation contributes to the prediction of immune checkpoint inhibitor efficacy in non-small cell lung cancer with high PD-L1 expression assessed by 22C3.SP142评估有助于预测通过22C3检测评估的高PD-L1表达的非小细胞肺癌中免疫检查点抑制剂的疗效。
Transl Lung Cancer Res. 2022 Dec;11(12):2438-2451. doi: 10.21037/tlcr-22-496.
10
Key changes to the World Health Organization (WHO) classification of female genital tumours introduced in the 5th edition (2020).世界卫生组织(世卫组织)女性生殖器官肿瘤分类的重大修订第五版(2020 年)。
Histopathology. 2022 Apr;80(5):762-778. doi: 10.1111/his.14609. Epub 2022 Feb 20.